sanjeri/E+ via Getty Images
SpringWorks Therapeutics (NASDAQ:SWTX) advanced 6.3% amid takeover speculation.
The biotech firm is said to be at the center of renewed takeover speculation, according to a Betaville “uncooked” alert that was circulating on Friday.
Last February, Betaville reported that SpringWorks (
